Clinical practice. Bipolar disorder--a focus on depression.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  New England Journal of Medicine

• Publication date

  2011-01-05

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1056/NEJMcp1000402PMID 21208108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

  2013cited by this paper
• Psychiatric diagnoses in patients who screen positive on the Mood Disorder Questionnaire: Implications for using the scale as a case-finding instrument for bipolar disorder.

  2011cited by this paper
• Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.

  2011cited by this paper
• Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

  2010cited by this paper
• A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

  2010cited by this paper
• Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.

  2010cited by this paper
• Screening for bipolar disorder and finding borderline personality disorder.

  2010cited by this paper
• Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis.

  2010cited by this paper
• A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).

  2010cited by this paper
• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

  2009cited by this paper
• Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

  2009cited by this paper
• Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

  2009cited by this paper
• Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.

  2009cited by this paper
• Long‐term antidepressant treatment in bipolar disorder: meta‐analyses of benefits and risks

  2008cited by this paper
• Aripiprazole Monotherapy in Nonpsychotic Bipolar I Depression: Results of 2 Randomized, Placebo-Controlled Studies

  2008cited by this paper
• Incidence and Time Course of Subsyndromal Symptoms in Patients With Bipolar I Disorder: An Evaluation of 2 Placebo-Controlled Maintenance Trials

  2008cited by this paper
• Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression

  2007cited by this paper
• Effectiveness of adjunctive antidepressant treatment for bipolar depression.

  2007cited by this paper
• A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.

  2007cited by this paper
• The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder.

  2007cited by this paper
• Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.

  2007cited by this paper
• Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.

  2007cited by this paper
• Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders.

  2007cited by this paper
• Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

  2007cited by this paper
• Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

  2006cited by this paper
• Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers.

  2006cited by this paper
• Tardive dyskinesia circa 2006.

  2006cited by this paper
• Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials.

  2006cited by this paper
• Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression: A Double-blind, Placebo-controlled Study (The BOLDER II Study)

  2006cited by this paper
• A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.

  2005cited by this paper
• A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

  2004cited by this paper
• Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.

  2004cited by this paper
• Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.

  2004cited by this paper
• Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

  2004cited by this paper
• Suicidal Behaviour in Bipolar Disorder

  2003cited by this paper
• Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder.

  2003cited by this paper
• Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

  2003cited by this paper
• Validity of the mood disorder questionnaire: a general population study.

  2003cited by this paper
• Subsyndromal depression is associated with functional impairment in patients with bipolar disorder.

  2002cited by this paper
• A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.

  2002cited by this paper
• The long-term natural history of the weekly symptomatic status of bipolar I disorder.

  2002cited by this paper
• Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.

  2001cited by this paper
• A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.

  2000cited by this paper
• Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.

  2000cited by this paper
• A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

  1999cited by this paper
• Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia

  1998cited by this paper
• Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

  1997cited by this paper

• Developing a Decision Support Tool to Guide Shared Decision‐Making in Bipolar Depression Treatment: Results From a Collaboration Between Clinicians and People With Lived Experience

  2025cites this paper
• Clinical Insights Into the Mechanistic Crossroads of Lamotrigine and Therapeutic Ketosis in Bipolar Depression

  2025cites this paper
• Unraveling the connections between migraine and psychiatric comorbidities: A narrative review.

  2025cites this paper
• Editorial: Old treatments new outcomes-augmentation treatments for depression

  2024cites this paper
• Delays in bipolar depression treatment in primary care vs. integrated behavioral health and specialty care.

  2024cites this paper
• Factors associated with higher quality of clinical practice guidelines and their recommendations for the pharmacological treatment of depression: a systematic review

  2023cites this paper
• Assessment and Management of Bipolar Disorder.

  2023cites this paper
• Quantification of diet quality utilizing the rapid eating assessment for participants-shortened version in bipolar disorder: Implications for prospective depression and cardiometabolic studies.

  2022cites this paper
• Ginsenoside Rh4 remodels the periphery microenvironment by targeting the brain-gut axis to alleviate depression-like behaviors.

  2022cites this paper
• Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania

  2022cites this paper
• Quality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review

  2022cites this paper
• TCF7L2 lncRNA: a link between bipolar disorder and body mass index through glucocorticoid signaling

  2021cites this paper
• Mood Disorders and Depression

  2021cites this paper
• Genome-Wide Association Study of Lithium-Induced Dry Mouth in Bipolar I Disorder

  2021cites this paper
• Genome-wide association study of early-onset bipolar I disorder in the Han Taiwanese population

  2021cites this paper
• Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection

  2020cites this paper
• Cost variability of antipsychotics according to pharmaceutical establishments in Lima, Peru.

  2020cites this paper
• Methylation of Brain Derived Neurotrophic Factor (BDNF) Val66Met CpG site is associated with early onset bipolar disorder.

  2020cites this paper
• Bhutonmada's of harita samhita: An explorative study

  2020cites this paper
• Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta‐analysis of randomized controlled trials

  2020cites this paper
• Severe anhedonia among adolescents with bipolar disorder is common and associated with increased psychiatric symptom burden.

  2020cites this paper
• Body mass index and blood pressure in bipolar patients: Target cardiometabolic markers for clinical practice.

  2020cites this paper
• Nitrous oxide as a putative novel dual-mechanism treatment for bipolar depression: Proof-of-concept study design and methodology

  2020cites this paper
• Mood‐Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome‐Wide Association Study

  2020cites this paper
• Pharmacologie des régulateurs de l’humeur

  2019cites this paper
• Bipolar disorder in primary care: a qualitative study of clinician and patient experiences with diagnosis and treatment

  2019cites this paper
• Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications

  2019cites this paper
• Decreased core symptoms of mania and utilization of lithium/mood stabilizing anticonvulsants in U.S. bipolar I patients of African vs European ancestry.

  2019cites this paper
• Clinical phenotype and genetic risk factors for bipolar disorder with binge eating: an update

  2019cites this paper
• Hybrid models in biomedical applications

  2019cites this paper
• Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications

  2019cites this paper
• High Frequency of Bipolar Disorder Comorbidity in Medical Inpatients

  2019cites this paper
• Effects of GADL1 overexpression on cell migration and the associated morphological changes

  2019cites this paper
• Systematic Review of Symptom Assessment Measures for Use in Measurement-Based Care of Bipolar Disorders.

  2019cites this paper
• Pharmacotherapy prescribing patterns in the treatment of bipolar disorder in a South African outpatient population

  2018cites this paper
• Epigenetic Drugs for Mood Disorders.

  2018cites this paper
• Clinical efficacy, onset time and safety of bright light therapy in acute bipolar depression as an adjunctive therapy: A randomized controlled trial.

  2018cites this paper
• Multistate Outcome and Persistent Benefit Analysis in Bipolar Mood Disorders

  2018cites this paper
• Exploring hepsin functional genetic variation association with disease specific protein expression in bipolar disorder: Applications of a proteomic informed genomic approach.

  2017cites this paper
• HCN Channel Targets for Novel Antidepressant Treatment

  2017cites this paper
• A genome wide association study suggests the association of muskelin with early onset bipolar disorder: Implications for a GABAergic epileptogenic neurogenesis model.

  2017cites this paper
• A Genome-Wide Search for Bipolar Disorder Risk Loci Modified by Mitochondrial Genome Variation

  2017cites this paper
• Reexamining associations between mania, depression, anxiety and substance use disorders: results from a prospective national cohort

  2017cites this paper
• The Diagnosis and Management of Bipolar I and II Disorders: Clinical Practice Update

  2017cites this paper
• Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy.

  2017cites this paper
• Psychopharmacological drug utilization patterns in pregnant women with bipolar disorder - A nationwide register-based study.

  2017cites this paper
• Early career psychiatrists

  2017cites this paper
• Evaluation of VNTR polymorphisms of dopamine transporter gene and the risk of bipolar disorder in Zahedan, southeast Iran

  2017cites this paper
• DRAFT Health Care Guideline Depression in Primary Care

  2016cites this paper
• Improving the Recognition of Borderline Personality Disorder in a Bipolar World.

  2016cites this paper
• KETAMINE FOR TREATMENT‐RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE

  2016cites this paper
• Accumulating evidence for a role of TCF7L2 variants in bipolar disorder with elevated body mass index

  2016cites this paper
• Are there subtypes of bipolar depression?

  2016cites this paper
• Clinical pearls in psychiatry.

  2016cites this paper
• Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania.

  2015cites this paper
• National Survey and Community Advisory Board Development for a Bipolar Disorder Biobank

  2015cites this paper
• The Relationship Between Sleep Disturbances and Psychiatric Disorders: Introduction and Overview.

  2015cites this paper
• Patient 125 – A 30-Year-Old Woman Who Has Difficulty Getting Out of Bed

  2015cites this paper
• Traditional and Alternative Treatments for Depression: Implications for Migraine Management

  2015cites this paper
• N-acetylaspartate normalization in bipolar depression after lamotrigine treatment.

  2015cites this paper
• Evaluation clinique spécialisée des troubles de l’humeur : impact sur le choix des traitements psychopharmacologiques pour les troubles bipolaires

  2015cites this paper
• Different patterns of manic/hypomanic symptoms in depression: A pilot modification of the hypomania checklist-32 to assess mixed depression.

  2015cites this paper
• Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide’s antiproliferative effect

  2015cites this paper
• Screening for bipolar spectrum disorders: A comprehensive meta-analysis of accuracy studies.

  2015cites this paper
• DEPRESSION IN CHILDREN AND ADOLESCENTS 2015 Edition

  2015cites this paper
• Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders

  2015cites this paper
• Borderline Personality Disorder: A Disorder in Search of Advocacy

  2015cites this paper
• Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses

  2015influential citation
• Title N-acetylaspartate normalization in bipolar depression after lamotrigine treatment

  2015cites this paper
• Variant GADL1 and response to lithium therapy in bipolar I disorder.

  2014cites this paper
• Enhancing Depression Mechanisms in Midbrain Dopamine Neurons Achieves Homeostatic Resilience

  2014cites this paper
• Managing the side effects associated with commonly used treatments for bipolar depression.

  2014cites this paper
• Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association.

  2014cites this paper
• Mindfulness-Based Cognitive Therapy for Bipolar Disorder

  2014cites this paper
• Risk of myocardial infarction and stroke in bipolar disorder: a systematic review and exploratory meta‐analysis

  2014cites this paper
• Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

  2014cites this paper
• [Long-term treatment of bipolar disorder].

  2014cites this paper
• [Pharmaceutical treatment of bipolar depression. Evidence from clinical guidelines and treatment recommendations].

  2014cites this paper
• Bipolar Disorder Symptoms in Patients Seeking Bariatric Surgery

  2014cites this paper
• The Challenge of Treatment in Bipolar Depression: Evidence from Clinical Guidelines, Treatment Recommendations and Complex Treatment Situations

  2014cites this paper
• Current landscape, unmet needs, and future directions for treatment of bipolar depression.

  2014cites this paper
• Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

  2014influential citation
• Screening for Bipolar Disorder: Confusion between Case-Finding and Screening

  2014cites this paper
• Clinical Practice Guidelines in Psychiatry: More Confusion Than Clarity? A Critical Review and Recommendation of a Unified Guideline

  2014cites this paper
• Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1/2 pathway

  2013cites this paper
• Antiepileptic drug effects on mood and behavior: molecular targets.

  2013cites this paper
• Using the mood disorder questionnaire and bipolar spectrum diagnostic scale to detect bipolar disorder and borderline personality disorder among eating disorder patients

  2013cites this paper
• Therapeutic implications for NMDA receptors in mood disorders

  2013cites this paper
• Generalizability of clinical trial results for bipolar disorder to community samples: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.

  2013cites this paper
• Acute Antidepressive Efficacy of Lithium Monotherapy, Not Citalopram, Depends on Recurrent Course of Depression

  2013cites this paper
• A factor analytic study in bipolar depression, and response to lamotrigine

  2013cites this paper
• Molecular Genetics of Bipolar Disorder

  2013cites this paper
• A Comparative Analysis of Victims of Sexual Assault With and Without Mental Health Histories: Acute and Follow-up Care Characteristics

  2013cites this paper
• Confidential consultations with adolescents: an exploration of Australian parents' perspectives.

  2013cites this paper
• Identifying Psychiatrists' Practice Patterns When Managing Depression in Patients with Bipolar I Disorder: A Descriptive Study to Inform Education Needs

  2013cites this paper
• Bipolar disorder and anxiety disorders.

  2013cites this paper
• Is antidepressant-associated mania always an evidence of a bipolar spectrum disorder? A case report and review of the literature.

  2013cites this paper
• Group interpersonal and social rhythm therapy for bipolar depression.

  2013cites this paper
• The Presentation, Recognition and Management of Bipolar Depression in Primary Care

  2013cites this paper
• Novel routes to bipolar disorder drug discovery

  2013influential citation